Growth Restriction and Genomic Imprinting-Overlapping Phenotypes Support the Concept of an Imprinting Network.

Prader-Willi syndrome Silver-Russell syndrome differentially methylated regions growth restriction imprinted gene network imprinting disorders overgrowth pseudoparahypoparathyreoidism temple syndrome transient neonatal diabetes

Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
17 04 2021
Historique:
received: 15 03 2021
revised: 09 04 2021
accepted: 13 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 13 8 2021
Statut: epublish

Résumé

Intrauterine and postnatal growth disturbances are major clinical features of imprinting disorders, a molecularly defined group of congenital syndromes caused by molecular alterations affecting parentally imprinted genes. These genes are expressed monoallelically and in a parent-of-origin manner, and they have an impact on human growth and development. In fact, several genes with an exclusive expression from the paternal allele have been shown to promote foetal growth, whereas maternally expressed genes suppress it. The evolution of this correlation might be explained by the different interests of the maternal and paternal genomes, aiming for the conservation of maternal resources for multiple offspring versus extracting maximal maternal resources. Since not all imprinted genes in higher mammals show the same imprinting pattern in different species, the findings from animal models are not always transferable to human. Therefore, human imprinting disorders might serve as models to understand the complex regulation and interaction of imprinted loci. This knowledge is a prerequisite for the development of precise diagnostic tools and therapeutic strategies for patients affected by imprinting disorders. In this review we will specifically overview the current knowledge on imprinting disorders associated with growth retardation, and its increasing relevance in a personalised medicine direction and the need for a multidisciplinary therapeutic approach.

Identifiants

pubmed: 33920525
pii: genes12040585
doi: 10.3390/genes12040585
pmc: PMC8073901
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Fetal Pediatr Pathol. 2018 Dec;37(6):387-399
pubmed: 30633605
Lancet Diabetes Endocrinol. 2021 Apr;9(4):235-246
pubmed: 33647242
Nat Rev Genet. 2018 May;19(5):325
pubmed: 29456250
Am J Med Genet A. 2016 Jan;170A(1):162-9
pubmed: 26333654
Clin Genet. 2020 Jun;97(6):902-907
pubmed: 32087029
Hum Reprod Update. 2020 Feb 28;26(2):197-213
pubmed: 32068234
Nat Genet. 2014 Jun;46(6):551-7
pubmed: 24816254
Front Pediatr. 2020 Sep 30;8:540718
pubmed: 33102403
Cell. 2019 Feb 21;176(5):952-965
pubmed: 30794780
Cell Mol Life Sci. 2019 Oct;76(20):4009-4021
pubmed: 31270580
J Med Genet. 2015 Jul;52(7):446-53
pubmed: 25951829
J Med Genet. 2019 Jun;56(6):413-418
pubmed: 30242100
Biomol Concepts. 2015 Mar;6(1):47-57
pubmed: 25581766
Dev Cell. 2006 Nov;11(5):711-22
pubmed: 17084362
Orphanet J Rare Dis. 2021 Jan 22;16(1):42
pubmed: 33482836
J Clin Endocrinol Metab. 2013 Oct;98(10):4013-22
pubmed: 24001750
Development. 2014 May;141(9):1805-13
pubmed: 24757003
Horm Res Paediatr. 2018;90(6):407-413
pubmed: 30836360
Clin Genet. 2017 Jul;92(1):45-51
pubmed: 28032339
Nat Rev Endocrinol. 2017 Feb;13(2):105-124
pubmed: 27585961
Acta Paediatr Suppl. 1997 Nov;423:50-4
pubmed: 9401539
Eur J Hum Genet. 2008 Apr;16(4):453-61
pubmed: 18197189
J Med Genet. 2020 Oct;57(10):683-691
pubmed: 32054688
Horm Res Paediatr. 2020;93(3):182-196
pubmed: 32756064
Trends Genet. 1991 Feb;7(2):45-9
pubmed: 2035190
Cold Spring Harb Perspect Biol. 2011 Jul 01;3(7):
pubmed: 21576252
J Clin Endocrinol Metab. 2018 Jul 1;103(7):2436-2446
pubmed: 29659920
Hum Mol Genet. 2014 Nov 1;23(21):5763-73
pubmed: 24916376
Mol Genet Genomic Med. 2017 Nov;5(6):668-677
pubmed: 29178649
Genet Med. 2018 Feb;20(2):250-258
pubmed: 28796236
Adv Exp Med Biol. 2018;1012:63-73
pubmed: 29956195
J Clin Endocrinol Metab. 2020 Jan 1;105(1):
pubmed: 31544945
Diabetologia. 2013 Apr;56(4):758-62
pubmed: 23385738
Pediatr Endocrinol Rev. 2017 Nov;15(Suppl 1):98-101
pubmed: 29292872
J Clin Endocrinol Metab. 2008 Nov;93(11):4183-97
pubmed: 18697869
J Clin Endocrinol Metab. 2016 May;101(5):2105-12
pubmed: 27007691
Trends Mol Med. 2014 Nov;20(11):614-22
pubmed: 25262539
Clin Genet. 2017 Jan;91(1):3-13
pubmed: 27363536
Nat Rev Genet. 2019 Apr;20(4):235-248
pubmed: 30647469
Genet Med. 2019 Aug;21(8):1808-1820
pubmed: 30635621
Arch Toxicol. 2019 Sep;93(9):2575-2592
pubmed: 31388691
Epigenetics. 2018;13(2):117-121
pubmed: 27911167
Development. 2009 Oct;136(20):3413-21
pubmed: 19762426
Nature. 2015 Feb 19;518(7539):409-12
pubmed: 25470045
Nat Genet. 2008 Aug;40(8):949-51
pubmed: 18622393
Eur J Hum Genet. 2014 Sep;22(9):
pubmed: 24736734
Proc Biol Sci. 2016 Feb 10;283(1824):
pubmed: 26842569
Genet Med. 2016 Apr;18(4):309-15
pubmed: 26248010
Am J Hum Genet. 2003 Mar;72(3):571-7
pubmed: 12545427
Arch Dis Child. 2008 Dec;93(12):1012-6
pubmed: 18263693
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2083-2088
pubmed: 29878129
Genet Med. 2017 Dec;19(12):1356-1366
pubmed: 28640239
Hum Mol Genet. 2013 Feb 1;22(3):544-57
pubmed: 23118352
Genet Med. 2012 Jan;14(1):10-26
pubmed: 22237428
J Clin Endocrinol Metab. 2017 Mar 1;102(3):983-991
pubmed: 28001454
J Endocrinol Invest. 2015 Dec;38(12):1249-63
pubmed: 26062517
J Med Genet. 2014 Aug;51(8):495-501
pubmed: 24891339
Sci Adv. 2019 Feb 20;5(2):eaau9425
pubmed: 30801013
Placenta. 2019 Sep 1;84:37-43
pubmed: 30871810
Nat Genet. 1995 Apr;9(4):395-400
pubmed: 7795645
Cell Rep. 2021 Feb 9;34(6):108729
pubmed: 33567274
Endocr Connect. 2018 May;7(5):663-672
pubmed: 29666169
Curr Opin Endocrinol Diabetes Obes. 2017 Feb;24(1):43-46
pubmed: 27898587
Eur J Hum Genet. 2015 Feb;23(2):
pubmed: 24896151
Nat Rev Endocrinol. 2018 Aug;14(8):476-500
pubmed: 29959430
Hum Mol Genet. 2009 Aug 15;18(16):3066-74
pubmed: 19487367

Auteurs

Thomas Eggermann (T)

Institute of Human Genetics, Medical Faculty, RWTH Aachen University, 52062 Aachen, Germany.

Justin H Davies (JH)

Department of Paediatric Endocrinology, University Hospital Southampton, Southampton SO16 6YD, UK.

Maithé Tauber (M)

Research centre of rare diseases PRADORT, Childrens Hospital, CHU Toulouse, Toulouse Institute of Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291-CNRS UMR5051-Tolouse III University, 31062 Toulouse, France.

Erica van den Akker (E)

Erasmus University Medical Center, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.

Anita Hokken-Koelega (A)

Erasmus University Medical Center, Pediatrics, Subdivision of Endocrinology, 3015 GD Rotterdam, The Netherlands.

Gudmundur Johansson (G)

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Department of Endocrinology, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.

Irène Netchine (I)

Medical Faculty, AP-HP, Armand Trousseau Hospital-Functional Endocrine Research Unit, INSERM, Research Centre Saint-Antoine, Sorbonne University, 75012 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH